首页 > 最新文献

Journal of Urology最新文献

英文 中文
Editorial Comment. 编辑评论。
IF 5.9 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-09-06 DOI: 10.1097/JU.0000000000004227
Mustafa Soytas, Rafael Sanchez-Salas
{"title":"Editorial Comment.","authors":"Mustafa Soytas, Rafael Sanchez-Salas","doi":"10.1097/JU.0000000000004227","DOIUrl":"https://doi.org/10.1097/JU.0000000000004227","url":null,"abstract":"","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":null,"pages":null},"PeriodicalIF":5.9,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142140441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Multi-Institutional Study of Magnetic Resonance/Ultrasound Fusion-Guided Nanoparticle-Directed Focal Therapy for Prostate Ablation. MR/US 融合引导的纳米粒子前列腺消融病灶疗法的多机构研究。
IF 5.9 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-09-03 DOI: 10.1097/JU.0000000000004222
Steven E Canfield, Arvin K George, Joshua S Jue, Sara C Lewis, Matthew S Davenport, Varaha S Tammisetti, Mahir Maruf, Leonardo D Borregalaes, Yara Kadria-Vili, Jon A Schwartz, Jennifer West, Naomi J Halas, Ardeshir R Rastinehad

Purpose: Focal therapy aims to provide a durable oncologic treatment option for men with prostate cancer (PCa), while preserving their quality of life. Most focal therapy modalities rely on the direct tissue effect, resulting in a possible nontargeted approach to ablation. Here, we report the results of the first human feasibility trial utilizing nanoparticle-directed focal photothermal ablation for PCa.

Materials and methods: A prospective, open-label, single-arm, multicenter study of men with localized PCa in Gleason Grade Group 1 to 3 was conducted. Men received a single infusion of gold nanoparticles (AuroShells), followed by magnetic resonance (MR)/ultrasound (US) fusion-guided laser excitation of the target tissue to induce photothermal ablation. MRI was used to assess the effectiveness of prostate tissue ablation at 48 to 96 hours, 3 months, and 12 months post treatment. At 3 months, a targeted fusion biopsy of the lesion(s) was conducted. At 12 months, a targeted fusion biopsy and standard templated biopsy were performed. Treatment success was determined based on a negative MR/US fusion biopsy outcome within the treated area.

Results: Forty-six men were enrolled in the study, and 44 men with 45 lesions completed nanoparticle infusion and laser treatment. The mean PSA level at baseline was 9.5 ng/mL, which decreased to 5.9 ng/mL at 3 months and to 4.7 ng/mL at 12 months (P < .0001). The oncologic success rates at 3 and 12 months resulted in 29 (66%) and 32 (73%) of 44 patients, respectively, being successfully treated, confirmed with negative MR/US fusion biopsies within the ablation zone. Among Gleason Grade Group, maximum lesion diameter on MRI, prostate volume, and Prostate Imaging Reporting and Data System scoring, the maximum lesion diameter was significantly associated with the odds of treatment failure at 12 months (P = .046).

Conclusions: Nanoparticle-directed focal laser ablation of neoplastic prostate tissue resulted in 73% of patients with successful treatment at 12 months post treatment, confirmed by negative MR/US fusion biopsy of the treated lesion and a systematic biopsy.

Clinical trial registration no.: 02680535.

简介病灶治疗旨在为前列腺癌(PCa)患者提供一种持久的肿瘤治疗方案,同时保证他们的生活质量。大多数病灶治疗模式都依赖于直接组织效应,这可能导致一种非靶向消融方法。在此,我们报告了利用纳米粒子引导的病灶光热消融治疗 PCa 的首个人体可行性试验的结果:一项前瞻性开放标签、单臂多中心研究针对患有局部 PCa 的男性进行,患者的 Gleason 等级组(GGG)为 1 至 3。男性患者接受一次金纳米粒子(AuroShells)输注,然后在 MR/US 融合引导下用激光激发靶组织,诱导光热消融。核磁共振成像用于评估治疗后 48 至 96 小时、3 个月和 12 个月的前列腺组织消融效果。3 个月时,对病灶进行靶向融合活检。12 个月时,进行靶向融合活检和标准模板活检。治疗成功与否取决于治疗区域内的 MR/US 融合活检结果是否为阴性:46名男性参加了这项研究,44名男性的45个病灶完成了纳米颗粒输注和激光治疗。基线PSA平均水平为9.5纳克/毫升,3个月时下降了5.9纳克/毫升,12个月时下降了4.7纳克/毫升(P < .0001)。根据 3 个月和 12 个月的肿瘤学成功率,44 例患者中分别有 29 例(66%)和 32 例(73%)治疗成功,消融区内的 MR/US 融合活检结果均为阴性。在GGG、MRI最大病灶直径(MLD)、前列腺体积和PI-RADS评分中,MLD与12个月时治疗失败的几率显著相关(P = .046):结论:对前列腺肿瘤组织进行纳米粒子定向病灶激光消融术可使73%的患者在治疗后12个月时获得成功治疗,治疗病灶的MR/US融合活检和系统活检结果均为阴性。
{"title":"A Multi-Institutional Study of Magnetic Resonance/Ultrasound Fusion-Guided Nanoparticle-Directed Focal Therapy for Prostate Ablation.","authors":"Steven E Canfield, Arvin K George, Joshua S Jue, Sara C Lewis, Matthew S Davenport, Varaha S Tammisetti, Mahir Maruf, Leonardo D Borregalaes, Yara Kadria-Vili, Jon A Schwartz, Jennifer West, Naomi J Halas, Ardeshir R Rastinehad","doi":"10.1097/JU.0000000000004222","DOIUrl":"10.1097/JU.0000000000004222","url":null,"abstract":"<p><strong>Purpose: </strong>Focal therapy aims to provide a durable oncologic treatment option for men with prostate cancer (PCa), while preserving their quality of life. Most focal therapy modalities rely on the direct tissue effect, resulting in a possible nontargeted approach to ablation. Here, we report the results of the first human feasibility trial utilizing nanoparticle-directed focal photothermal ablation for PCa.</p><p><strong>Materials and methods: </strong>A prospective, open-label, single-arm, multicenter study of men with localized PCa in Gleason Grade Group 1 to 3 was conducted. Men received a single infusion of gold nanoparticles (AuroShells), followed by magnetic resonance (MR)/ultrasound (US) fusion-guided laser excitation of the target tissue to induce photothermal ablation. MRI was used to assess the effectiveness of prostate tissue ablation at 48 to 96 hours, 3 months, and 12 months post treatment. At 3 months, a targeted fusion biopsy of the lesion(s) was conducted. At 12 months, a targeted fusion biopsy and standard templated biopsy were performed. Treatment success was determined based on a negative MR/US fusion biopsy outcome within the treated area.</p><p><strong>Results: </strong>Forty-six men were enrolled in the study, and 44 men with 45 lesions completed nanoparticle infusion and laser treatment. The mean PSA level at baseline was 9.5 ng/mL, which decreased to 5.9 ng/mL at 3 months and to 4.7 ng/mL at 12 months (<i>P</i> < .0001). The oncologic success rates at 3 and 12 months resulted in 29 (66%) and 32 (73%) of 44 patients, respectively, being successfully treated, confirmed with negative MR/US fusion biopsies within the ablation zone. Among Gleason Grade Group, maximum lesion diameter on MRI, prostate volume, and Prostate Imaging Reporting and Data System scoring, the maximum lesion diameter was significantly associated with the odds of treatment failure at 12 months (<i>P</i> = .046).</p><p><strong>Conclusions: </strong>Nanoparticle-directed focal laser ablation of neoplastic prostate tissue resulted in 73% of patients with successful treatment at 12 months post treatment, confirmed by negative MR/US fusion biopsy of the treated lesion and a systematic biopsy.</p><p><strong>Clinical trial registration no.: </strong>02680535.</p>","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":null,"pages":null},"PeriodicalIF":5.9,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142125994","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enzalutamide in Men With High-Risk Biochemically Recurrent Prostate Cancer: Rationale and Treatment Considerations From EMBARK. 恩杂鲁胺在高风险生化复发性前列腺癌男性患者中的应用:来自 EMBARK 的理由和治疗考虑。
IF 5.9 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-09-03 DOI: 10.1097/JU.0000000000004228
Neal D Shore, Ugo De Giorgi, Stephen J Freedland
{"title":"Enzalutamide in Men With High-Risk Biochemically Recurrent Prostate Cancer: Rationale and Treatment Considerations From EMBARK.","authors":"Neal D Shore, Ugo De Giorgi, Stephen J Freedland","doi":"10.1097/JU.0000000000004228","DOIUrl":"10.1097/JU.0000000000004228","url":null,"abstract":"","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":null,"pages":null},"PeriodicalIF":5.9,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142125995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply by Authors. 作者回复。
IF 5.9 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-09-03 DOI: 10.1097/JU.0000000000004221
Neal Shore, Christopher Pieczonka, Sean Heron, Mukaram Gazi, David Cahn, Laurence H Belkoff, Aaron Berger, Brian Mazzarella, Joseph Veys, Charles Idom, David Morris, Gautam Jayram, Alexander Engelman, Paul Dato, Richard Bevan-Thomas, David R Wise, Mary Kay Hardwick, Susan Rojahn, Paige Layman, Brandie Heald, Rachel E Ellsworth, Kathryn E Hatchell, Robert L Nussbaum, Sarah M Nielsen, Edward D Esplin
{"title":"Reply by Authors.","authors":"Neal Shore, Christopher Pieczonka, Sean Heron, Mukaram Gazi, David Cahn, Laurence H Belkoff, Aaron Berger, Brian Mazzarella, Joseph Veys, Charles Idom, David Morris, Gautam Jayram, Alexander Engelman, Paul Dato, Richard Bevan-Thomas, David R Wise, Mary Kay Hardwick, Susan Rojahn, Paige Layman, Brandie Heald, Rachel E Ellsworth, Kathryn E Hatchell, Robert L Nussbaum, Sarah M Nielsen, Edward D Esplin","doi":"10.1097/JU.0000000000004221","DOIUrl":"https://doi.org/10.1097/JU.0000000000004221","url":null,"abstract":"","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":null,"pages":null},"PeriodicalIF":5.9,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142125996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter: The AUA/SUFU Guideline on the Diagnosis and Treatment of Idiopathic Overactive Bladder. 信:AUA/SUFU 特发性膀胱过度活动症诊断和治疗指南。
IF 5.9 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-09-01 Epub Date: 2024-05-30 DOI: 10.1097/JU.0000000000004063
Annah Vollstedt, Rachel Rubin
{"title":"Letter: The AUA/SUFU Guideline on the Diagnosis and Treatment of Idiopathic Overactive Bladder.","authors":"Annah Vollstedt, Rachel Rubin","doi":"10.1097/JU.0000000000004063","DOIUrl":"10.1097/JU.0000000000004063","url":null,"abstract":"","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":null,"pages":null},"PeriodicalIF":5.9,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141175058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter: Lower Urinary Tract Symptoms in US Women: Contemporary Prevalence Estimates From the RISE FOR HEALTH Study. 信美国妇女的下尿路症状:来自 RISE FOR HEALTH 研究的当代患病率估计值。
IF 5.9 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-09-01 Epub Date: 2024-06-07 DOI: 10.1097/JU.0000000000004067
Giulia M Ippolito
{"title":"Letter: Lower Urinary Tract Symptoms in US Women: Contemporary Prevalence Estimates From the RISE FOR HEALTH Study.","authors":"Giulia M Ippolito","doi":"10.1097/JU.0000000000004067","DOIUrl":"10.1097/JU.0000000000004067","url":null,"abstract":"","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":null,"pages":null},"PeriodicalIF":5.9,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141284050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evidence-Based Guidelines in Urology: A Way Forward Together. 泌尿外科循证指南:共同前进。
IF 5.9 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-09-01 Epub Date: 2024-06-07 DOI: 10.1097/JU.0000000000004062
Philipp Dahm, Daniel A Gonzalez-Padilla, Holger J Schünemann
{"title":"Evidence-Based Guidelines in Urology: A Way Forward Together.","authors":"Philipp Dahm, Daniel A Gonzalez-Padilla, Holger J Schünemann","doi":"10.1097/JU.0000000000004062","DOIUrl":"10.1097/JU.0000000000004062","url":null,"abstract":"","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":null,"pages":null},"PeriodicalIF":5.9,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141288296","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trauma, and Genital and Urethral Reconstruction. 创伤以及生殖器和尿道重建。
IF 5.9 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-09-01 Epub Date: 2024-05-30 DOI: 10.1097/JU.0000000000004019
Sean P Elliott
{"title":"Trauma, and Genital and Urethral Reconstruction.","authors":"Sean P Elliott","doi":"10.1097/JU.0000000000004019","DOIUrl":"10.1097/JU.0000000000004019","url":null,"abstract":"","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":null,"pages":null},"PeriodicalIF":5.9,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141175320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial Comment. 编辑评论。
IF 5.9 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-09-01 Epub Date: 2024-06-12 DOI: 10.1097/JU.0000000000004084
Jessica Yih
{"title":"Editorial Comment.","authors":"Jessica Yih","doi":"10.1097/JU.0000000000004084","DOIUrl":"10.1097/JU.0000000000004084","url":null,"abstract":"","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":null,"pages":null},"PeriodicalIF":5.9,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141902150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply by Authors. 作者回复。
IF 5.9 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-09-01 Epub Date: 2024-06-18 DOI: 10.1097/JU.0000000000004112
Landon Trost, John Mulhall, Wayne Hellstrom
{"title":"Reply by Authors.","authors":"Landon Trost, John Mulhall, Wayne Hellstrom","doi":"10.1097/JU.0000000000004112","DOIUrl":"10.1097/JU.0000000000004112","url":null,"abstract":"","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":null,"pages":null},"PeriodicalIF":5.9,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141902155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Urology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1